Description
MK-3697 is a selective orexin 2 receptor antagonist.
Product Unit Size | Cost | Quantity | Stock |
---|
MK-3697 is a selective orexin 2 receptor antagonist.
Cas No. | 1224846-01-8 |
---|---|
Purity | ≥98% |
Formula | C23H21N5O3S |
Formula Wt. | 447.5 |
Chemical Name | N-[(5,6-dimethoxypyridin-2-yl)methyl]-2-(5-methylpyridin-3-yl)-5-(1,3-thiazol-2-yl)pyridine-4-carboxamide |
IUPAC Name | N-[(5,6-dimethoxypyridin-2-yl)methyl]-2-(5-methylpyridin-3-yl)-5-(1,3-thiazol-2-yl)pyridine-4-carboxamide |
Synonym | MK3697; M8238285OA; (2,3'-Bipyridine)-4-carboxamide, N-((5,6-dimethoxy-2-pyridinyl)methyl)-5'-methyl-5-(2-thiazolyl)- |
Solubility | Insoluble in water. DMSO (>20 mg/mL). |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Roecker AJ, Reger TS, Mattern MC. et.al. Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia. Bioorg Med Chem Lett. (2014) 24:4884-90. PMID: 25248679 DOI: 10.1016/j.bmcl.2014.08.041.
Endogenous neuropeptide, also known as substanc...
Endogenous amino acid sugar involved in cartila...
Potential voltage-gated Na+ channel blocker.
PRMT5 inhibitor
Purine derivative; CDK inhibitor.
G-quadruplex ligand; DNA breakage inducer.
CDK inhibitor.
GLP-1/GIP receptor co-agonist
PI3K inhibitor.
Deubiquitinating enzyme inhibitor.
Endogenous tachykinin peptide, involved in infl...
Alkaloid found in Sophora.
Endogenous peptide, involved in stress signalin...
p110δ PI3K inhibitor.
Synthetic glycyrrhetinic acid derivative; 11β-...
HDAC inhibitor.
Nitrogen mustard, DNA alkylator.
Endogenous opioid peptide; μOR agonist.
FAAH inhibitor.
Triterpene saponin found in species of Panax.